Sign up
Log in
Salesforce, AbbVie, Intuitive Surgical And An Industrial Stock On CNBC's 'Final Trades'
Share
Listen to the news

On CNBC's “Halftime Report Final Trades,” Joshua Brown, CEO and co-founder, Ritholtz Wealth Management, said he is staying long on 3M Company (NYSE:MMM).

Supporting his view, 3M reported better-than-expected first-quarter financial results on Tuesday. The company reported net sales of $5.95 billion, a 1.0% decline year-over-year (Y/Y), beating the consensus of $ 5.78 billion. Adjusted EPS was $1.88, up 10% Y/Y, beating the consensus of $1.77.

Jim Lebenthal of Cerity Partners picked AbbVie Inc. (NYSE:ABBV) as his final trade.

Lending support to his choice, Cantor Fitzgerald analyst Carter Gould initiated coverage of AbbVie on Tuesday with an Overweight rating and a price target of $210.

Don't forget to check out our premarket coverage here

Rob Sechan of New Edge Capital Group named Salesforce, Inc. (NYSE:CRM) as his final trade.

Guggenheim analyst John Difucci upgraded Salesforce from Sell to Neutral on Monday.

Stephanie Link of Hightower picked Intuitive Surgical, Inc. (NASDAQ:ISRG) as her final trade.

On the earnings front, Intuitive Surgical reported first-quarter revenue of $2.25 billion on Tuesday, beating analyst estimates of $2.19 billion. The robotic-assisted surgery company reported first-quarter adjusted earnings of $1.81 per share, beating analyst estimates of $1.72 per share.

Price Action:

  • 3M shares jumped 8.1% to close at $136.33 on Tuesday.
  • AbbVie gained 2.1% to close at $173.78 during Tuesday's session.
  • Salesforce shares rose 3% to close at $243.39 on Tuesday.
  • Intuitive Surgical shares climbed 2.2% to settle at $478.74 during the session.

Check This Out:

Photo: Shutterstock

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.